DWM
BIIB icon

Darwin Wealth Management’s Biogen BIIB Stock Holding History

Darwin Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.93K Hold
16
– – ﹤0.01% 458
2025
Q4 		$2.81K Hold
16
– – ﹤0.01% 500
2025
Q3 		$2.24K Hold
16
– – ﹤0.01% 492
2025
Q2 		$2.01K Hold
16
– – ﹤0.01% 488
2025
Q1 		$2.45K Hold
16
– – ﹤0.01% 499
2024
Q4 		$2.45K Hold
16
– – ﹤0.01% 499
2024
Q3 		$3.1K Buy
+16
New +$3.35K ﹤0.01% 491
2021
Q4 		– Sell
-4,250
Closed -$1.2M – 169
2021
Q3 		$1.2M Buy
+4,250
New +$1.39M 0.19% 79
2020
Q2 		– Sell
-20
Closed -$6K – 213
2020
Q1 		$6K Buy
+20
New +$6.07K ﹤0.01% 565

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Darwin Wealth Management's BIIB Position: Q1 2026 in Review

Darwin Wealth Management held its Biogen (BIIB) position steady in Q1 2026 at 16 shares worth $2.93K. The position accounts for ﹤0.01% of the portfolio, ranked #458.

Darwin Wealth Management first reported a position in BIIB in Q1 2020 and has held it in 9 quarters since. The position peaked at $1.2M in Q3 2021. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Darwin Wealth Management held 16 shares of Biogen worth $2.93K as of Q1 2026.
  • Darwin Wealth Management left its Biogen share count unchanged in Q1 2026.
  • Biogen made up ﹤0.01% of Darwin Wealth Management's portfolio in Q1 2026, its #458 holding.
  • Darwin Wealth Management first reported a position in Biogen in Q1 2020 and has held it in 9 quarters since.
  • Darwin Wealth Management's Biogen position peaked at $1.2M in Q3 2021.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Darwin Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.